Duphar Bioscience Private Limited
About Duphar Bioscience Private Limited
Data last updated:
Duphar Bioscience Private Limited is a private limited company based in Ahmedabad, Gujarat, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 01 July 2011 and has been in existence for over 15 years.
The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U24239GJ2011PTC066132.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Riteshkumar Dineshkumar Thakkar and Sangeetaben Hasmukhlal Thakkar.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 434 Ratnmani Complex 4th Floor Nr. Nagarsheth Vendo Gheekanta, Ahmedabad, Gujarat, India – 380001.
As per the financials filed for FY 2025, the company reported a revenue of ₹10,600. For the same year it recorded a net loss of ₹1,247 (net margin -11.8%) and EBITDA of -₹1,247 (EBITDA margin -11.8%). Revenue has grown at a compounded annual rate (CAGR) of 7% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Duphar Bioscience Private Limited's registered office is in Ahmedabad, Gujarat. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address434 Ratnmani Complex 4th Floor Nr. Nagarsheth Vendo Gheekanta, Ahmedabad, Gujarat, India – 380001
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Duphar Bioscience Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Duphar Bioscience Private Limited
FY 2025 filings availableDuphar Bioscience Private Limited reported revenue of ₹10,600 for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 7% over five years. EBITDA rose 89% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹1,247 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹1,247 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -11.8% | ||||
| Net Profit Margin | -11.8% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Duphar Bioscience Private Limited, buy the company report.
Board of directors of Duphar Bioscience Private Limited
Duphar Bioscience has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Riteshkumar Dineshkumar Thakkar Also directs: Duphar Lifesciences Private Limited, RHT Pharmaceuticals Private Limited, Roussel Laboratories Private Limited and 1 more | Director | 01 Jul 2011 | 15 Years 3 Months | Current |
| Sangeetaben Hasmukhlal Thakkar | Director | 24 Nov 2015 | 10 Years 11 Months | Current |
Auditor
Duphar Bioscience Private Limited is audited by PALAK J SHAH & CO for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| PALAK J SHAH & CO | FY 2022 | 124911W |
Shareholding
The shareholding of Duphar Bioscience Private Limited is on record for 5 financial years, the latest being FY 2022, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Duphar Bioscience Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Duphar Bioscience Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Duphar Bioscience Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Duphar Bioscience Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Duphar Bioscience Private Limited has 3 board changes on record since 2011: 2 appointments and 1 cessation. The latest: Hasmukhbhai N Thakkar ceased to be Director on 24 Nov 2015.
Frequently asked questions
Duphar Bioscience is an active private limited company based in Ahmedabad, Gujarat, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 01 July 2011 (15+ years old) and is registered under CIN U24239GJ2011PTC066132.
Duphar Bioscience has 2 current directors:
- Riteshkumar Dineshkumar Thakkar - Director
- Sangeetaben Hasmukhlal Thakkar - Director
The latest financial statements of Duphar Bioscience on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The CIN (Corporate Identification Number) of Duphar Bioscience is U24239GJ2011PTC066132. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Duphar Bioscience was incorporated on 01 July 2011, making it 15+ years old. It is registered with the Registrar of Companies, Ahmedabad.
Hasmukhbhai N Thakkar ceased to be Director on 24 Nov 2015. Sangeetaben Hasmukhlal Thakkar was appointed as Director on 24 Nov 2015. Riteshkumar Dineshkumar Thakkar was appointed as Director on 01 Jul 2011.
The registered office of Duphar Bioscience is at 434 Ratnmani Complex 4th Floor Nr. Nagarsheth Vendo Gheekanta, Ahmedabad, Gujarat, India – 380001.
Duphar Bioscience operates in the pharma industry, in the drug formulation and development segment.
The compliance status of Duphar Bioscience is compliant as of 21 August 2026. The company is actively filing with the Registrar of Companies.
Duphar Bioscience can be reached at its registered office: 434 Ratnmani Complex 4th Floor Nr. Nagarsheth Vendo Gheekanta, Ahmedabad, Gujarat, India – 380001.